Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belsomra for sleep and delirium in cardiac ICU
NCT04092894Phase 4Completed
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Feb 2020
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suvorexant in Insomnia, postoperative delirium (POD), sponsored by Beth Israel Deaconess Medical Center. Started Feb 2020; status: completed.
02
Drugs
suvorexant
03
Conditions
Insomniapostoperative delirium (POD)
Beyond the preview
Go deeper on NCT04092894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04092894.